{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:18:06Z","timestamp":1789021086673,"version":"build-2803163510"},"reference-count":24,"publisher":"Japanese Circulation Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2023,3,24]]},"DOI":"10.1253\/circj.cj-22-0683","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T22:12:52Z","timestamp":1677881572000},"page":"508-516","source":"Crossref","is-referenced-by-count":27,"title":["Impact of Tafamidis on Echocardiographic Cardiac Function of Patients With Transthyretin Cardiac Amyloidosis"],"prefix":"10.1253","volume":"87","author":[{"given":"Yasushi","family":"Ichikawa","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Oota","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Odajima","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Kintsu","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"Todo","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimikazu","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Yamauchi","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Shiraki","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terunobu","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Hisamatsu","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Hirata","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Maurer MS, Elliott P, Comenzo R, Semigran M, Rapezzi C. Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis. <i>Circulation<\/i> 2017; 135: 1357\u20131377.","DOI":"10.1161\/CIRCULATIONAHA.116.024438"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS. Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. <i>J Am Coll Cardiol<\/i> 2019; 73: 2872\u20132891.","DOI":"10.1016\/j.jacc.2019.04.003"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kitaoka H, Izumi C, Izumiya Y, Inomata T, Ueda M, Kubo T, et al. JCS 2020 guideline on diagnosis and treatment of cardiac amyloidosis. <i>Circ J<\/i> 2020; 84: 1610\u20131671.","DOI":"10.1253\/circj.CJ-20-0110"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, et al. Diagnosis and treatment of cardiac amyloidosis: A position statement of the ESC working group on myocardial and pericardial diseases. <i>Eur Heart J<\/i> 2021; 42: 1554\u20131568.","DOI":"10.1093\/eurheartj\/ehab072"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Wechalekar AD, Gillmore JD, Hawkins PN. Systemic amyloidosis. <i>Lancet<\/i> 2016; 387: 2641\u20132654.","DOI":"10.1016\/S0140-6736(15)01274-X"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kyle RA, Spittell PC, Gertz MA, Li CY, Edwards WD, Olson LJ, et al. The premortem recognition of systemic senile amyloidosis with cardiac involvement. <i>Am J Med<\/i> 1996; 101: 395\u2013400.","DOI":"10.1016\/S0002-9343(96)00229-X"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ng B, Connors LH, Davidoff R, Skinner M, Falk RH. Senile systemic amyloidosis presenting with heart failure: A comparison with light chain-associated amyloidosis. <i>Arch Intern Med<\/i> 2005; 165: 1425\u20131429.","DOI":"10.1001\/archinte.165.12.1425"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Connors LH, Sam F, Skinner M, Salinaro F, Sun F, Ruberg FL, et al. Heart failure resulting from age-related cardiac amyloid disease associated with wild-type transthyretin: A prospective, observational cohort study. <i>Circulation<\/i> 2016; 133: 282\u2013290.","DOI":"10.1161\/CIRCULATIONAHA.115.018852"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Grogan M, Scott CG, Kyle RA, Zeldenrust SR, Gertz MA, Lin G, et al. Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system. <i>J Am Coll Cardiol<\/i> 2016; 68: 1014\u20131020.","DOI":"10.1016\/j.jacc.2016.06.033"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yamashita T, Ando Y, Okamoto S, Misumi Y, Hirahara T, Ueda M, et al. Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy. <i>Neurology<\/i> 2012; 78: 637\u2013643.","DOI":"10.1212\/WNL.0b013e318248df18"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Koike H, Tanaka F, Hashimoto R, Tomita M, Kawagashira Y, Iijima M, et al. Natural history of transthyretin val30 met familial amyloid polyneuropathy: Analysis of late-onset cases from non-endemic areas. <i>J Neurol Neurosurg Psychiatry<\/i> 2012; 83: 152\u2013158.","DOI":"10.1136\/jnnp-2011-301299"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. <i>N Engl J Med<\/i> 2018; 379: 1007\u20131016.","DOI":"10.1056\/NEJMoa1805689"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. <i>Eur Heart J Cardiovasc Imaging<\/i> 2015; 16: 233\u2013270.","DOI":"10.1093\/ehjci\/jev014"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. <i>Am J Cardiol<\/i> 1986; 57: 450\u2013458.","DOI":"10.1016\/0002-9149(86)90771-X"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Phelan D, Collier P, Thavendiranathan P, Popovic ZB, Hanna M, Plana JC, et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. <i>Heart<\/i> 2012; 98: 1442\u20131448.","DOI":"10.1136\/heartjnl-2012-302353"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ochi Y, Kubo T, Baba Y, Sugiura K, Miyagawa K, Noguchi T, et al. Early experience of tafamidis treatment in japanese patients with wild-type transthyretin cardiac amyloidosis from the Kochi amyloidosis cohort. <i>Circ J<\/i> 2022; 86: 1121\u20131128.","DOI":"10.1253\/circj.CJ-21-0965"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Rettl R, Mann C, Duca F, Dachs TM, Binder C, Ligios LC, et al. Tafamidis treatment delays structural and functional changes of the left ventricle in patients with transthyretin amyloid cardiomyopathy. <i>Eur Heart J Cardiovasc Imaging<\/i> 2022; 23: 767\u2013780.","DOI":"10.1093\/ehjci\/jeab226"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Giblin GT, Cuddy SAM, Gonzalez-Lopez E, Sewell A, Murphy A, Dorbala S, et al. Effect of tafamidis on global longitudinal strain and myocardial work in transthyretin cardiac amyloidosis. <i>Eur Heart J Cardiovasc Imaging<\/i> 2022; 23: 1029\u20131039.","DOI":"10.1093\/ehjci\/jeac049"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Gonzalez-Lopez E, Gallego-Delgado M, Guzzo-Merello G, de Haro-Del Moral FJ, Cobo-Marcos M, Robles C, et al. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. <i>Eur Heart J<\/i> 2015; 36: 2585\u20132594.","DOI":"10.1093\/eurheartj\/ehv338"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Tanaka H. Efficacy of echocardiography for differential diagnosis of left ventricular hypertrophy: Special focus on speckle-tracking longitudinal strain. <i>J Echocardiogr<\/i> 2021; 19: 71\u201379.","DOI":"10.1007\/s12574-020-00508-3"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Castano A, Narotsky DL, Hamid N, Khalique OK, Morgenstern R, DeLuca A, et al. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. <i>Eur Heart J<\/i> 2017; 38: 2879\u20132887.","DOI":"10.1093\/eurheartj\/ehx350"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Nitsche C, Scully PR, Patel KP, Kammerlander AA, Koschutnik M, Dona C, et al. Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis. <i>J Am Coll Cardiol<\/i> 2021; 77: 128\u2013139.","DOI":"10.1016\/j.jacc.2020.11.006"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Law S, Bezard M, Petrie A, Chacko L, Cohen OC, Ravichandran S, et al. Characteristics and natural history of early-stage cardiac transthyretin amyloidosis. <i>Eur Heart J<\/i> 2022; 43: 2622\u20132632.","DOI":"10.1093\/eurheartj\/ehac259"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Elliott P, Drachman BM, Gottlieb SS, Hoffman JE, Hummel SL, Lenihan DJ, et al. Long-term survival with tafamidis in patients with transthyretin amyloid cardiomyopathy. <i>Circ Heart Fail<\/i> 2022; 15: e008193.","DOI":"10.1161\/CIRCHEARTFAILURE.120.008193"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/87\/4\/87_CJ-22-0683\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T03:22:35Z","timestamp":1679714555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/87\/4\/87_CJ-22-0683\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,24]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-22-0683","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,24]]},"article-number":"CJ-22-0683"}}